{
    "organizations": [],
    "uuid": "3cc4f780f7d0e7d9768dbd2e930e09d2d3ef4df4",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-benitec-biopharma-says-us-fda-gran/brief-benitec-biopharma-says-u-s-fda-granted-orphan-drug-designation-to-bb-301-idUSFWN1P712R",
    "ord_in_thread": 0,
    "title": "BRIEF-Benitec Biopharma ‍Says U.S. FDA Granted Orphan Drug Designation To BB-301​",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 15 (Reuters) - Benitec Biopharma Ltd:\n* ‍U.S. FDA HAS GRANTED ORPHAN DRUG DESIGNATION TO BB-301 FOR TREATMENT OF OCULOPHARYNGEAL MUSCULAR DYSTROPHY(OPMD)​ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-01-15T06:05:00.000+02:00",
    "crawled": "2018-01-15T16:54:12.007+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "benitec",
        "biopharma",
        "ltd",
        "fda",
        "granted",
        "orphan",
        "drug",
        "designation",
        "treatment",
        "oculopharyngeal",
        "muscular",
        "dystrophy",
        "opmd",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}